Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA's Overreach on Compounded Peptides BPC 157 Kit Research for Tissue Repair Pathways Hydration Room Q&A: Should you trust trending peptide injections? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York